In the validation cohort, analyzed by qPCR, we observed a decreasing trend in the levels of CTSL and TRPV2 in MDD patients and an increasing trend in ZNF713, which was consistent with the transcriptomic results (Figure 6g). The gene discussed is TRPV2; the disease is major depressive disorder.